CPX-351对比“7+3”化疗在初诊高危或继发性急性髓系白血病老年患者中的5年随访结果

    5-Year Follow-Up Results of CPX-351 Versus 7+3 Chemotherapy in Older Adults With Newly Diagnosed High-Risk or Secondary Acute Myeloid Leukaemia

    /

    返回文章
    返回